StemCell Therapy

April 21, 2017 6:21am NASDAQ:IBB

From Taki Tsaklanos: Stock market indexes gain around 1 percent on Thursday. The small cap index Russell 2000 rose around of 1.15%, making it the best performing U.S. stock market index of the day.

How meaningful was todays strong day in the stock market mean in the bigger picture?

In order to answer that question, investors should turn to leading stock market indicators. In this article, two leading indicators are revised: the transportation index and biotechnology.

Based on the current set up of these two indicators, InvestingHavens research team believes there is a fair chance that stocks particularly in the U.S. are going nowhere.

First, the transportation index is simply bouncing back from a retracement which brought the index down from 9550 to 8800 points. Transportations are now slightly recovering, but in the bigger picture of things they are still trading near major support, see the circle on the first chart.

As long as there is no clear direction here, the odds favor a trendless market. Investors watch for a potential divergence between transportations and the Dow Jones index which would be bearish according to the Dow Theory.

Furthermore, although not a leading indicator, the biotechnology sector is certainly a health indicator. Right now, biotech is simply moving sideways. We have noticed several times that biotech was about to break down or, recently, break out. But the sector did refuse to go either direction, it is basically going sideways.

Because of the setup in those two stock market indicators, InvestingHaven believes that the stock market could follow their trendless state, and basically go nowhere in the coming months. The question is: will bulls or bears first give up during this nerve wracking situation?

The iShares NASDAQ Biotechnology Index ETF (NASDAQ:IBB) was unchanged in premarket trading Friday. Year-to-date, IBB has gained 9.41%, versus a 5.28% rise in the benchmark S&P 500 index during the same period.

IBB currently has an ETF Daily News SMART Grade of B (Buy), and is ranked #20 of 36 ETFs in the Health & Biotech ETFs category.

This article is brought to you courtesy of Investing Haven.

Tags: biotech Equity Health Care NASDAQ:IBB Taki Tsaklanos

Categories: NASDAQ:IBB

See the original post here:
Will Biotech Bulls Or Bears Blink First? - ETF Daily News (blog)

This entry was posted on April 21, 2017 at 10:42 pm and is filed under Biotechnology. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |